Holen Sie sich die Stockscreener-App
0.384
0.21%
-0.0008
Handel nachbörslich:
.39
0.006
+1.56%
Curanex Pharmaceuticals Inc Aktie (CURX) Neueste Nachrichten
Curanex adds two advisors to scientific board ahead of IND filing By Investing.com - Investing.com India
Curanex adds two advisors to scientific board ahead of IND filing - Investing.com South Africa
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers - The Manila Times
TB and COVID scientists join Curanex board to steer 2026 trial plans - Stock Titan
Curanex adds two pharmaceutical veterans to advisory board - Investing.com India
Curanex adds two pharmaceutical veterans to advisory board By Investing.com - Investing.com Nigeria
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board - Yahoo Finance Singapore
Curanex Formalizes Long-Term Executive Employment and Compensation Agreements - TipRanks
Curanex Pharmaceuticals Inc Enters into Executive Employment Agreement with Jun Liu as President and Chairman of the Board, Effective March 1, 2026 - marketscreener.com
Curanex Forms World Class Scientific Advisory Board - Bitget
Botanical drug firm Curanex taps Fortune 100 pharma exec to guide R&D - Stock Titan
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
Market Movers | Winners: IXHL, ALBT, RXT | Losers: THRY, EOSE, ERII - Trefis
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Thursday's session: most active stocks - ChartMill
Unusual volume stocks are being observed in Thursday's session. - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Curanex Pharmaceuticals Stock Soars 56.32% After Key IND Milestone - Intellectia AI
24,000,000 Common Stock of Curanex Pharmaceuticals Inc are subject to a Lock-Up Agreement Ending on 26-FEB-2026. - marketscreener.com
Curanex Pharmaceuticals IncCommon Stock (Nasdaq:CURX) Stock Quote - The Chronicle-Journal
Top movers in Wednesday's after hours session - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Curanex completes GMP pilot batch for ulcerative colitis drug - Investing.com
Curanex Completes GMP Pilot For Phyto-N, Targets IND Submission In Ulcerative Colitis - Nasdaq
Curanex provides operational update on key regulatory milestones - marketscreener.com
Curanex completes GMP pilot batch for ulcerative colitis drug By Investing.com - Investing.com South Africa
Curanex Provides Operational Update on Key Regulatory Milestones - GlobeNewswire
Comparing Curanex Pharmaceuticals (CURX) & The Competition - Defense World
Curanex Pharmaceuticals (CURX) versus Its Peers Financial Survey - Defense World
Financial Contrast: Curanex Pharmaceuticals (CURX) & Its Peers - Defense World
Curanex Pharmaceuticals appoints new chief financial officer - MSN
Contrasting Curanex Pharmaceuticals (CURX) and The Competition - Defense World
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation By Investing.com - Investing.com Nigeria
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation - Investing.com
Curanex Pharmaceuticals (CURX) Competitors and Alternatives 2026 - MarketBeat
Curanex Pharmaceuticals Appoints New Chief Financial Officer - TipRanks
Curanex Pharmaceuticals Announces CFO Transition - TradingView — Track All Markets
Curanex Pharmaceuticals Inc Announces Executive Changes - marketscreener.com
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):